ACLY was one of 73 genes consistently upregulated in MASH-HCC across all pairwise comparisons (Fig. 5n and Extended Data Fig. 12a,b), suggesting that its overexpression in malignant tissue is not confounded by intermediate disease states. The gene discussed is ACLY; the disease is hepatocellular carcinoma.